Responsiveness to stem cell factor (SCF) of peripheral blood colony-forming cells from patients with myelodysplastic syndromes (MDS)
- 31 August 1995
- journal article
- Published by Elsevier in Leukemia Research
- Vol. 19 (8) , 561-566
- https://doi.org/10.1016/0145-2126(95)00034-l
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Serum stem cell factor concentration in patients with myelodysplastic syndromesBritish Journal of Haematology, 1993
- In vivo administration of recombinant methionyl human stem cell factor expands the number of human marrow hematopoietic stem cellsBlood, 1993
- Interleukin 3 and interleukin 3/gm‐csf combination therapy ‐ clinical implicationsThe International Journal of Cell Cloning, 1993
- Recombinant Erythropoietin in Myelodysplastic Syndromes: Whom to Treat and How? More Questions than AnswersActa Haematologica, 1993
- The ligand for c-kit, stem cell factor, stimulates the circulation of cells that engraft lethally irradiated baboonsBlood, 1992
- Kit ligand improves in vitro erythropoiesis in myelodysplastic syndromeBlood, 1992
- Mast cell growth factor (c-kit ligand) supports the growth of human multipotential progenitor cells with a high replating potentialBlood, 1991
- Recombinant human stem cell factor, a c-kit ligand, stimulates hematopoiesis in primatesBlood, 1991
- Proliferative properties of unfractionated, purified, and single cell human progenitor populations stimulated by recombinant human interleukin-3Blood, 1990
- The myelodysplastic syndrome: analysis of laboratory characteristics in relation to the FAB classificationBritish Journal of Haematology, 1985